Quantcast

Expression Of Gelatinases In Gastric Cancer And Superficial Gastritis

April 8, 2010

Gastric cancer in Mexico is the most frequent gastrointestinal malignant neoplasm. Several precursor conditions, such as chronic gastritis, have been associated with the development of gastric cancer. The gelatinases MMP-2 and MMP-9, members of the metalloproteinase family, are fundamental enzymes in extracellular matrix remodeling. The extracellular matrix is composed of secreted molecules outside cells which provides structural support and regulates cell behavior.

The matrix metalloproteinase family is a group of 24 enzymes in humans that degrade components of extracellular matrix. The gelatinases comprise MMP-2 (gelatinase A) and MMP-9 (gelatinase B), both of which cleave several components of the extracellular matrix.

A research article to be published on March 28, 2010 in the World Journal of Gastroenterology. The authors reported that MMP9 expression is enhanced in gastric cancer compared to normal gastric mucosa; also they found no differences in MMP2 and MMP9 expression between superficial gastritis and normal tissue. This is important because gene expression profiles allow characterization of differentially expressed genes and those are considered key determinants of cellular behavior. Knowledge about differences in gene expression profiles between normal gastric mucosa, precursor conditions and malignant tissue, is central to elucidating regulatory pathways involved in cancer development and progression. Future research efforts of this team are directed to profiling all members of the matrix metalloproteinases family in larger groups of Mexican patients with gastritis and gastric cancer.

Reference: Sampieri CL, de la Peña S, Ochoa-Lara M, Zenteno-Cuevas R, Le³n-C³rdoba K. Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis. World J Gastroenterol 2010; 16(12): 1500-1505

On the Net:




comments powered by Disqus